Tourmaline Bio

Yahoo Finance • last year

Tourmaline Bio to Present at Upcoming Investor Conferences

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Nasdaq: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune dise... Full story